Press Release
Comer Seeks Briefing on Biden Administration’s Medicare Part D Redesign Over Concerns of Higher Drug Prices and Reduced Access
WASHINGTON—Today, House Committee on Oversight and Government Reform Chairman James Comer (R-Ky.) is conducting oversight of the Medicare Part D program amid reports that Part D plans and Pharmacy Benefit Managers (PBMs) are restricting access to certain prescription drugs and pressuring manufacturers to raise rebates—and ultimately prices—to offset the costs imposed by the Biden Administration’s Inflation Reduction Act’s (IRA) Part D redesign. In a letter to the Centers for ...
